Tenaya Therapeutics is a biopharmaceutical company with a mission to discover, develop, and deliver potentially curative treatments that target the underlying causes of heart disease. Tenaya is advancing multiple candidates from three product platforms - Cellular Regeneration, Gene Therapy, and Precision Medicine. Headquartered in South San Francisco, California, Tenaya was founded by world-leading scientists from the Gladstone Institute's Cardiovascular Division and from the University of Texas Southwestern Medical Center.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 10/04/19 | $92,000,000 | Series B |
Casdin Capital GV The Column Group | undisclosed |
| 03/02/21 | $106,000,000 | Series C |
Casdin Capital Fidelity Management & Research Company GV RA Capital Management RTW Investments  T. Rowe Price Associates The Column Group | undisclosed |
